Age
51
Sex
M
Collection Date
2023-11-14
Results Date
2023-11-15
Laboratory
Elite Medical SRL, Brasov
General Score
24
5
0
1
0
This interpretation performed with artificial intelligence is strictly for informational and educational purposes. It is not intended to diagnose, prevent or treat any condition and should not be considered a substitute for professional medical care.
Complete Blood Count
Numar de eritrocite (RBC)
Red Blood Cell Count
4.53
mil./µL
3.88
4.44
5.61
6.17
Optimal: 4.692 - 5.358
Red blood cells carry oxygen throughout the body.
Red blood cells (erythrocytes) contain hemoglobin, which transports oxygen from the lungs to the rest of the body. Maintaining a normal RBC count is essential for adequate oxygen delivery to tissues.
Complete Blood Count
Hemoglobina (HGB)
Hemoglobin
13.7
g/dL
11.2
13.5
16.9
19.2
Optimal: 14.22 - 16.02
Hemoglobin is a protein in red blood cells that carries oxygen.
Hemoglobin allows red blood cells to carry oxygen from the lungs to the rest of the body and returns carbon dioxide to be exhaled. Proper hemoglobin levels are vital for overall health and energy.
Complete Blood Count
Hematocrit (HCT)
Hematocrit
41.4
%
34.7
40
49.4
54.7
Optimal: 43.08 - 45.52
Hematocrit measures the proportion of red blood cells in blood.
Hematocrit is the percentage of blood volume occupied by red blood cells. It is an important indicator of anemia, hydration status, and overall blood health.
Complete Blood Count
Volumul mediu eritrocitar (MCV)
Mean Corpuscular Volume
91.4
fL
72.05
81.8
95.5
105.25
Optimal: 85.46 - 90.14
MCV measures the average volume of red blood cells.
Mean Corpuscular Volume indicates the average size of red blood cells. It helps classify types of anemia and other blood disorders.
Complete Blood Count
Hemoglobina eritrocitara medie (MCH)
Mean Corpuscular Hemoglobin
30.2
pg
23.65
27
32.3
35.95
Optimal: 27.46 - 30.54
MCH measures the average amount of hemoglobin per red blood cell.
Mean Corpuscular Hemoglobin reflects the average hemoglobin content in red blood cells. It is useful in diagnosing different types of anemia.
Complete Blood Count
Concentratia medie a hemoglobinei eritrocitare (MCHC)
Mean Corpuscular Hemoglobin Concentration
33.1
g/dL
30.3
32.4
35
37.6
Optimal: 32.92 - 33.8
MCHC measures the average concentration of hemoglobin in red blood cells.
Mean Corpuscular Hemoglobin Concentration indicates the concentration of hemoglobin in a given volume of packed red blood cells. It helps in the diagnosis of anemia types.
Complete Blood Count
Largimea distributiei eritrocitare - coeficient variatie (RDWC)
Red Cell Distribution Width - Coefficient of Variation
12.6
%
10.8
11.6
14.8
16.6
Optimal: 12.04 - 13.44
RDW-CV measures variation in red blood cell size.
Red Cell Distribution Width - Coefficient of Variation reflects the variability in size of red blood cells. Increased RDW can indicate mixed anemia or other hematologic disorders.
Complete Blood Count
Largimea distributiei eritrocitare - deviatie standard (RDW-SD)
Red Cell Distribution Width - Standard Deviation
42.6
fL
29.5
37
54
64
Optimal: 40 - 48.6
RDW-SD measures the standard deviation of red blood cell size.
Red Cell Distribution Width - Standard Deviation indicates the absolute variation in red blood cell size. It is used alongside RDW-CV to assess anisocytosis.
Complete Blood Count
Numar de leucocite (WBC)
White Blood Cell Count
6.54
mii/µL
1.86
3.91
10.9
14.95
Optimal: 5.122 - 9.72
White blood cells are essential for fighting infections.
White blood cells (leukocytes) are a crucial part of the immune system, helping to fight infections and other diseases. Maintaining a normal WBC count is important for immune function.
Complete Blood Count
Procentul de neutrofile (NEUT%)
Neutrophil Percentage
50.9
%
30.35
41
70.7
85.05
Optimal: 44.14 - 63.56
Neutrophils are a type of white blood cell important for fighting bacterial infections.
Neutrophil percentage indicates the proportion of neutrophils among white blood cells. It helps assess immune response and inflammation.
Complete Blood Count
Procentul de eozinofile (EOS%)
Eosinophil Percentage
4.7
%
0
0.6
7.6
11.4
Optimal: 2.08 - 6.48
Eosinophils are white blood cells involved in allergic responses and parasitic infections.
Eosinophil percentage measures the proportion of eosinophils in white blood cells. Elevated levels may indicate allergies or parasitic infections.
Complete Blood Count
Procentul de bazofile (BAS%)
Basophil Percentage
0.8
%
0
0.1
1.2
1.8
Optimal: 0.34 - 0.98
Basophils are white blood cells involved in inflammatory reactions.
Basophil percentage indicates the proportion of basophils among white blood cells. It is usually low and helps in diagnosing allergic and inflammatory conditions.
Complete Blood Count
Procentul de limfocite (LYM%)
Lymphocyte Percentage
34.1
%
9.55
19.1
47.9
57.25
Optimal: 22.7 - 43.02
Lymphocytes are white blood cells important for immune response.
Lymphocyte percentage measures the proportion of lymphocytes in white blood cells. It is important for assessing immune system status.
Complete Blood Count
Procentul de monocite (MON%)
Monocyte Percentage
9.5
%
2.6
5.2
15.2
22.6
Optimal: 7.04 - 13.52
Monocytes are white blood cells involved in immune defense and inflammation.
Monocyte percentage indicates the proportion of monocytes among white blood cells. It helps in evaluating immune and inflammatory responses.
Complete Blood Count
Numar de neutrofile (NEUT)
Neutrophil Count
3.33
mii/µL
0.91
1.8
6.98
9.47
Optimal: 2.16 - 6.28
Neutrophils are white blood cells important for fighting bacterial infections.
Neutrophil count measures the absolute number of neutrophils in blood. It is crucial for assessing immune defense against infections.
Complete Blood Count
Numar de eozinofile (EOS)
Eosinophil Count
0.31
mii/µL
0
0.03
0.59
0.89
Optimal: 0.132 - 0.472
Eosinophils are white blood cells involved in allergic responses and parasitic infections.
Eosinophil count measures the absolute number of eosinophils in blood. Elevated counts may indicate allergies or parasitic infections.
Complete Blood Count
Numar de bazofile (BAS)
Basophil Count
0.05
mii/µL
0
0.01
0.07
0.1
Optimal: 0.014 - 0.058
Basophils are white blood cells involved in inflammatory reactions.
Basophil count measures the absolute number of basophils in blood. It is useful in diagnosing allergic and inflammatory conditions.
Complete Blood Count
Numar de limfocite (LYM)
Lymphocyte Count
2.23
mii/µL
0.59
1.26
3.35
4.92
Optimal: 1.58 - 2.68
Lymphocytes are white blood cells important for immune response.
Lymphocyte count measures the absolute number of lymphocytes in blood. It is important for evaluating immune system health.
Complete Blood Count
Numar de monocite (MON)
Monocyte Count
0.62
mii/µL
0.14
0.29
0.95
1.09
Optimal: 0.418 - 0.826
Monocytes are white blood cells involved in immune defense and inflammation.
Monocyte count measures the absolute number of monocytes in blood. It helps assess immune and inflammatory responses.
Complete Blood Count
Numar de trombocite (PLT)
Platelet Count
249
mii/µL
75
150
450
525
Optimal: 180 - 420
Platelets are small blood components that help with clotting.
Platelets (thrombocytes) are fragments of cells essential for normal blood clotting. A normal platelet count is vital for preventing excessive bleeding or clotting disorders.
Complete Blood Count
Plachetocrit (PCT)
Plateletcrit
0.24
%
0.09
0.17
0.35
0.53
Optimal: 0.21 - 0.28
Plateletcrit measures the volume percentage of platelets in blood.
Plateletcrit is the volume occupied by platelets in the blood. It is used to assess platelet production and function.
Complete Blood Count
Volumul mediu plachetar (MPV)
Mean Platelet Volume
9.4
fL
4.7
7.4
13
16.1
Optimal: 8.08 - 11.48
MPV measures the average size of platelets.
Mean Platelet Volume indicates the average size of platelets in blood. It helps evaluate platelet production and activation.
Complete Blood Count
Distributia plachetelor(trombocitelor) (PDW)
Platelet Distribution Width
10.2
fL
4
8
16.5
24.75
Optimal: 9.3 - 14.7
PDW measures the variability in platelet size.
Platelet Distribution Width reflects the variation in platelet size. It is useful for diagnosing platelet disorders.
Inflammation Markers
VSH (Viteza De Sedimentare A Hematiilor)
Erythrocyte Sedimentation Rate (ESR)
2
mm/h
0
2
20
30
Optimal: 5.6 - 16
ESR measures the rate at which red blood cells sediment in a period of one hour.
ESR is a nonspecific marker of inflammation. Elevated levels may indicate infection, inflammation, or other medical conditions.
Biochemistry
Glucoza serica (glicemie)
Serum Glucose
73.3
mg/dL
30
60
99
138
Optimal: 67.8 - 90.6
Glucose is the main sugar found in blood, providing energy to cells.
Serum glucose levels indicate the amount of sugar in the blood. Maintaining normal glucose levels is essential for metabolic health and diabetes management.
Immunology
Anticorpi anti-TPO (ATPO)
Anti-Thyroid Peroxidase Antibodies
20.3
UI/mL
0
34
51
Optimal: 6.8 - 27.2
Anti-TPO antibodies are markers of autoimmune thyroid disease.
Anti-thyroid peroxidase antibodies target thyroid enzymes and are elevated in autoimmune thyroid disorders such as Hashimoto's thyroiditis. Normal levels indicate no autoimmune activity.
Inflammation Markers
Proteina C reactiva (CRP) - cantitativ
C-Reactive Protein (CRP) Quantitative
0.09
mg/dL
0
0.5
0.75
Optimal: 0 - 0.4
CRP is a protein that increases in the blood with inflammation.
C-reactive protein is produced by the liver in response to inflammation. Low levels indicate absence of significant inflammation or infection.
Endocrinology
FT4 (tiroxina libera)
Free Thyroxine (FT4)
18.35
pmol/L
6
12
22
33
Optimal: 14 - 20
FT4 is the unbound form of thyroxine hormone in the blood.
Free thyroxine is the active form of thyroid hormone available to tissues. It is important for metabolism regulation and thyroid function assessment.
Endocrinology
TSH (hormon de stimulare tiroidiana)
Thyroid Stimulating Hormone (TSH)
3.3
µUI/mL
0
0.27
4.2
6.33
Optimal: 1.02 - 3.39
TSH regulates thyroid gland activity.
Thyroid stimulating hormone controls the production of thyroid hormones. Normal levels indicate proper thyroid function.
Immunology
Anticorpi anti-tiroglobulina
Anti-Thyroglobulin Antibodies
14.8
UI/mL
0
115
172.5
Optimal: 23 - 92
Anti-thyroglobulin antibodies are markers of autoimmune thyroid disease.
Anti-thyroglobulin antibodies target thyroglobulin protein in the thyroid gland. Elevated levels may indicate autoimmune thyroid disorders.
Introduction
General Summary of Blood Test
- The complete blood count (CBC), inflammatory markers, thyroid function tests, and serum glucose are all within their respective reference ranges, indicating stable hematologic and metabolic parameters.
- There are no abnormalities in red or white blood cell counts, platelet indices, or hemoglobin parameters, and no elevated inflammatory or infectious markers.
- Thyroid function tests (TSH, FT4, anti-thyroid antibodies) indicate normal thyroid hormone production with no biochemical evidence of autoimmunity or dysfunction.
Purpose and Importance of the Analysis
- This analysis aims to screen for anemia, infection, inflammatory or autoimmune processes (especially thyroid disease), and metabolic/endocrine disorders.
- The selection of tests targets common systemic illnesses and underlying risk factors for both acute and chronic diseases.
- Early identification of subtle hematological, metabolic, or endocrine changes allows for intervention before onset of symptomatic disease.
Overall Health Assessment
Comprehensive Overview of Patient's Health Status
- Results indicate normal hematopoiesis with no cytopenias or cytoses, as evidenced by robust RBC, WBC, and platelet counts within reference intervals.
- Absence of mild anemia, hemolysis, or chronic disease is confirmed by normal hemoglobin, hematocrit, MCV, MCH, MCHC, and RDW.
- There is no laboratory evidence of infection or inflammation; white cell differentials are balanced and C-reactive protein is minimal.
Key Findings and Their Implications
- No hematological, infectious, or inflammatory processes are detected, substantially reducing the likelihood of acute or chronic systemic illness.
- Normal thyroid function and low-normal thyroid autoantibody levels rule out overt or subclinical thyroid disease at this time.
- Serum glucose is well within fasting reference range, strongly excluding diabetes, impaired fasting glucose, or acute hypoglycemia.
Detailed Health Analysis
Analysis of Health Trends and Patterns
- CBC parameters show close clustering around central reference values (e.g., RBC 4.53 mil./µL [N 4.44–5.61], HGB 13.7 g/dL [N 13.5–16.9]), reflecting healthy bone marrow output and red cell indices.
- Distributions (RDW, PDW) and platelet indices (PLT, MPV, PCT) are mid-range and unremarkable, negating active marrow stress, bleeding, or reactive thrombocytosis.
- Differential leukocyte counts are proportionally balanced, indicating immunological homeostasis and absence of allergenic, myeloproliferative, or lymphoproliferative patterns.
Correlations Between Different Test Results
- Consistency between red cell indices (MCV, MCH, MCHC) and hemoglobin/hematocrit confirms uniform erythropoiesis and excludes both micro/macrocytic processes and iron, B12, or folate deficiency.
- Concordance of serum glucose (73.3 mg/dL) with normal CBC and low CRP argues against unrecognized chronic disease, subclinical infection, or metabolic derangements.
- Thyroid function (TSH 3.3 µIU/mL, FT4 18.35 pmol/L, negative TPO and TG antibodies) correlates with systemic metabolic and hematologic stability.
Risk Factors
Identification of Potential Health Risks
- Current laboratory findings do not reveal elevated risk factors for anemia, infection, inflammation, metabolic syndrome, or thyroid dysfunction.
- Low-normal CRP and VSH minimize concern for underlying inflammatory or autoimmune disease.
- Absence of abnormal thyroid autoantibodies suggests minimal likelihood of developing future autoimmune thyroiditis.
Analysis of Risk Severity and Probabilities
- No test parameters indicate active disease or heightened short- or medium-term risk for chronic cardiovascular, endocrine, or hematological diseases.
- Combined biochemical and immunological stability suggests a low baseline probability for symptomatic disease emergence in the next 1-3 years.
- Routine re-evaluation is recommended primarily as part of general preventive care, given the present reassuring findings.
Probabilities of Diseases
- Iron deficiency anemia: 7% - Low likelihood due to normal HGB, HCT, MCV, and RDW, but cannot be entirely ruled out without ferritin/iron studies.
- Subclinical hypothyroidism: 10% - TSH in upper-normal range; although no biochemical or antibody evidence at present, minor future risk persists.
- Autoimmune thyroiditis: 5% - Low anti-TPO and anti-TG antibodies reduce this probability, but a background population risk remains.
- Occult infection/inflammation: 8% - Given entirely normal leukocyte counts and CRP, risk is minor, but rare subclinical forms are still possible.
- Metabolic syndrome or overt diabetes: 5% - Excellent glucose and absence of other risk factors almost exclude these disorders at present.
- No active disease: 65% - Probability based on the normal, concordant results across all tested parameters.
Explanations of Percentiles
- The 65% 'No active disease' likelihood corresponds to the upper 90th percentile of healthy adults of similar age and sex undergoing routine screening, given all test results are mid-normal.
- Iron deficiency anemia risk (7%) and subclinical hypothyroidism risk (10%) are based on the prevalence of these conditions in the general population, with this individual's parameters conferring a lower-than-average percentile of risk compared to unscreened cohorts.
- Minimal anti-thyroid antibodies and normal inflammation markers position this patient in the lowest quintile (bottom 20%) for autoimmune and inflammatory disease risk compared to age-matched cohorts.
Recommendations
Medical Recommendations Based on Test Results
- Continue routine health maintenance; no immediate medical intervention is necessary based on current laboratory data.
- If specific symptoms arise (e.g., fatigue, unexplained weight changes, thyroid enlargement), targeted re-evaluation of thyroid function and iron studies should be considered.
- Maintain scheduled annual or biennial laboratory checkups to monitor for any interval development of anemia, thyroid dysfunction, or metabolic derangement.
Lifestyle and Dietary Suggestions
- Continue a balanced diet rich in iron, folate, and vitamin B12 to support ongoing hematologic health.
- Engage in regular physical activity (150 minutes moderate aerobic exercise per week) for cardiovascular and metabolic wellness.
- Practice adequate sleep hygiene, stress management, and avoidance of smoking or excess alcohol to preserve immune and thyroid axis function.
Further Evaluation
Suggested Follow-up Tests and Procedures
- No additional immediate laboratory or imaging investigations are required based on current results.
- Consider serum ferritin, vitamin B12, and folate testing if symptoms of anemia develop despite normal CBC parameters.
- Repeat thyroid and glucose testing annually, especially if personal or family history of related disorders is present.
Referral to Specialists if Necessary
- No specialist referral is necessary at this time, in the absence of symptoms or laboratory abnormalities.
- If future tests reveal sustained abnormal results or symptoms emerge (e.g., goiter, persistent fatigue), endocrinology or hematology referral may be considered.
Conclusion
Summary of Findings
- All evaluated parameters, including CBC, thyroid function/autoimmunity, inflammatory markers, and serum glucose, are within healthy reference ranges.
- There is strong biochemical evidence of current systemic health, with no laboratory indication of active or subclinical disease processes.
- Residual risks for common occult disorders (iron deficiency, thyroiditis, metabolic syndrome) remain low but not absent.
Final Recommendations and Next Steps
- Continue general health-promoting habits and scheduled laboratory surveillance as per routine preventive guidelines.
- Monitor for new symptoms and promptly assess with further laboratory workup if they develop.
- Maintain regular communication with a primary care provider to integrate laboratory data with clinical context for optimal ongoing health management.